THE MERCK VETERINARY MANUAL
Print Topic

Sections

Chapters

Overview of Immunologic Diseases

-
-

The primary role of the immune system is the detection and destruction of invading microorganisms. Because of the great diversity of microbial invaders, the immune system has evolved an equally complex mixture of protective mechanisms. These may be simply classified as innate immunity (see Innate Immunity) and adaptive immunity (see Adaptive Immunity). Protection within the first few days of microbial invasion is the responsibility of the “hard-wired” innate immune system. Longterm protection is the responsibility of the adaptive immune system.

In general, disease associated with the immune system takes two forms: insufficient immune function causing immunodeficiencies, manifested as increased susceptibility to infections, and diseases resulting from excessive immune function, resulting in hypersensitivities and autoimmunity.

Under certain circumstances, normally protective immune responses can cause significant tissue damage. In general, excessive innate immune responses do this by triggering inappropriate inflammation leading to collateral damage to nearby tissues, or by producing vastly excessive amounts of inflammatory cytokines. Excessive adaptive immune responses, in contrast, can cause damage by multiple mechanisms. One simple classification divides diseases due to excessive adaptive immune responses into four distinct types. Each involves the activities of different cell populations or complement. Type I is mediated by mast cells and eosinophils, Type II by complement and some macrophages, Type III by neutrophils, and Type IV is T cell-mediated.

Inflammation and limited tissue destruction are features of the normal innate and adaptive immune responses. Clinical disease occurs when this inflammation is excessive or in an inappropriate location. This may be due to external environmental factors, such as the composition of the intestinal microflora, together with genetic and hormonal influences.

Last full review/revision September 2013 by Ian Tizard, BVMS, PhD, DACVM

Copyright     © 2009-2015 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A.    Privacy    Terms of Use    Permissions